Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 15, 2021.
Article Versions
- Latest version (September 15, 2020 - 04:00).
- You are currently viewing a Latest version of this article (April 15, 2021 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2021 The Journal of Rheumatology
Author Information
- Melissa L. Mannion,
- Fenglong Xie,
- Daniel B. Horton,
- Sarah Ringold,
- Colleen K. Correll,
- Anne Dennos and
- Timothy Beukelman; for the CARRA Registry Investigators
- This project was supported by funding from the Childhood Arthritis and Rheumatology Research Alliance.
M.L. Mannion, MD, MSPH, Assistant Professor, T. Beukelman, MD, MSCE, Associate Professor, Division of Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; F. Xie, PhD, MS, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; D.B. Horton, MD, MSCE, Assistant Professor, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, and Rutgers Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, New Brunswick, and Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey; S. Ringold, MD, MS, Assistant Professor, Division of Pediatric Rheumatology, Seattle Children’s Hospital, Seattle, Washington; C.K. Correll, MD, MPH, Assistant Professor, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota; 6A. Dennos, MSPH, Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA.
TB declares conflicts with Novartis and UCB. The remaining authors declare no conflicts of interest.
Address corresponding author to Dr. M.L. Mannion,1600 7th Ave South, CPPN G10, Birmingham, AL 35233, USA. Email: mmannion@peds.uab.edu.
Accepted for publication August 26, 2020.